Continuous Bioprocessing Technologies Market - Global Forecast 2026-2031 | Market to Reach USD 8.5 Billion as Automation and Biologics Demand Fuel 12.1% CAGR

The global continuous bioprocessing technologies market is projected to grow from USD 4.8 billion in 2026 to USD 8.5 billion by 2031, driven by rising biologics demand, regulatory support, and the biopharmaceutical industry's shift from batch to continuous production. Key growth drivers include cost efficiency, improved quality, and faster time to market, though high capital investment and technical complexity remain challenges.

10/01/2026, 11:00 AM • GlobeNewswire

Global Automated and Closed Cell Therapy Processing Systems Market Set for Expansion as Scalable Workflows Drive Growth, 2026-2033

The global automated and closed cell therapy processing systems market is projected to reach USD 7.0 billion by 2033, expanding at a CAGR of 20.2%. Growth is driven by increasing investment in regenerative medicine, CAR-T cell therapies, and personalized medicine. Non-stem cell therapy leads the type segment, while pre-commercial/R&D-scale applications dominate by scale. North America leads regionally, with LAMEA posting the fastest regional growth at 21.6% CAGR.

09/24/2026, 4:56 AM • GlobeNewswire

Bioprocess Automation Market Poised for Robust Growth Through 2033, Driven by Demand for Efficient, Scalable Biomanufacturing

The global bioprocess automation market is projected to grow from USD 8.6 billion in 2025 to USD 22.2 billion by 2033, expanding at a CAGR of 12.8%. Growth is driven by rising demand for biologics, advances in AI and robotics, and pressure to improve manufacturing efficiency and regulatory compliance. Automation technologies enhance throughput, consistency, and cost-effectiveness while reducing errors and production time.

09/15/2026, 5:57 AM • GlobeNewswire

Global Single-use Bioreactors Market Forecast to Surge from USD 3.61 Billion in 2025 to USD 15.11 Billion by 2034

The global single-use bioreactors market is projected to experience robust growth with a CAGR of 17.27%, expanding from USD 3.61 billion in 2025 to USD 15.11 billion by 2034. Growth is driven by increasing biopharmaceutical demand, cost efficiency advantages, and technological advancements in bioprocessing. North America is expected to dominate, while Asia-Pacific shows rapid expansion. Major players include Sartorius, Thermo Fisher Scientific, and Cytiva, with recent developments including new product launches and facility expansions.

07/03/2026, 5:12 AM • GlobeNewswire

Global Pharmaceutical Filtration Market to Double by 2034: Insights on Driving Factors

The global pharmaceutical filtration market is expected to grow at a CAGR of 8.13% from 2025 to 2034, driven by rising biopharmaceutical demand, CDMO expansion, and increased sterile drug manufacturing. North America leads the market, while Asia-Pacific emerges as a rapidly growing region. Major players are investing in capacity expansion and acquisitions to meet growing demand, though high operational costs and filter clogging challenges persist.

07/03/2026, 4:43 AM • GlobeNewswire

Global Sterile Bioprocess Filtration Market Set to Surge, Projected to Reach USD 31.33 Billion by 2034

The global sterile bioprocess filtration market is projected to grow from USD 6.50 billion in 2025 to USD 31.33 billion by 2034, at a CAGR of 19.13%. Growth is driven by rising biopharmaceutical and vaccine demand, outsourcing to CMOs/CDMOs, and technological advancements. North America is expected to lead the market, with membrane filters dominating the product segment.

07/03/2026, 4:42 AM • GlobeNewswire

Global Laboratory Equipment Services Market Size/Share Worth USD 62.83 Billion by 2035 at a 8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

The global laboratory equipment services market is projected to grow from USD 28.94 billion in 2025 to USD 62.83 billion by 2035, at a CAGR of 8%. Growth is driven by increased R&D investments in life sciences, stricter regulatory compliance requirements, expansion of biopharma facilities, and adoption of IoT-enhanced predictive maintenance technologies. Repair and maintenance services represent the largest market segment, with North America dominating and Asia Pacific showing the fastest growth.

06/24/2026, 3:30 PM • GlobeNewswire

Why Elliott Sees Hidden Billions Inside Bio-Rad Laboratories

Activist investor Elliott Investment Management has built a significant stake in Bio-Rad Laboratories and is expected to push for improvements. The company's Sartorius stake is valued at roughly $5 billion, nearly equal to Bio-Rad's $6.6 billion market cap. Bio-Rad shares surged 12.94% on the news, though the stock has fallen over 70% from its 2021 pandemic peak. The company faces margin pressures with 2026 guidance of 10-12%, well below historical levels and industry peers.

05/18/2026, 2:34 PM • Benzinga

[Latest] Global Cell Culture Media Bags Market Size/Share Worth USD 2.28 Billion by 2035 at a 5.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

The global cell culture media bags market is valued at USD 1.30 billion in 2025 and is projected to reach USD 2.28 billion by 2035, growing at a CAGR of 5.8%. Growth is driven by increased R&D investments in life sciences, adoption of single-use bioprocessing technologies, and automation trends in biopharmaceutical manufacturing. Single-use bags and EVA materials dominate the market segments, with North America leading in market share and Asia Pacific showing the highest growth rate.

04/29/2026, 12:30 AM • GlobeNewswire

[Latest] Global Pharmaceutical Microbiology QC Testing Market Size/Share Worth USD 17.65 Billion by 2035 at a 13.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)

The global Pharmaceutical Microbiology QC Testing Market is projected to grow from USD 5.08 billion in 2025 to USD 17.65 billion by 2035, at a CAGR of 13.27%. Growth is driven by increased regulatory oversight, laboratory automation, antimicrobial resistance concerns, and adoption of advanced technologies like AI-enabled molecular platforms and MALDI-TOF mass spectrometry. North America leads with 39.12% market share, while Asia Pacific is expected to grow fastest at 14.33% CAGR.

03/10/2026, 2:00 PM • GlobeNewswire

Cell Therapy Processing Market to Grow 21.4% Annually Through 2030

The global cell therapy processing market is projected to grow from $2.7 billion in 2025 to $7.1 billion by 2030, at a CAGR of 21.4%. Growth is driven by rising demand for advanced cell therapies including CAR-T, increasing R&D investments, expanding clinical trials, and an aging population with chronic diseases. Key challenges include complex manufacturing, regulatory hurdles, and workforce shortages. North America leads the market with the highest share.

02/05/2026, 1:47 PM • GlobeNewswire

Single-Use Bioprocessing Market Projected to Reach US$ 122.92 Billion by 2035, Supported by Expansion of Biomanufacturing Capacity Says Astute Analytica

The global single-use bioprocessing market is expected to grow from USD 30.12 billion in 2025 to USD 122.92 billion by 2035 at a CAGR of 15.1%. Driven by technological breakthroughs in bioreactor scalability (up to 6,000L), 40-50% CAPEX reductions, and FDA approvals of 16 single-use-manufactured biologics in 2024, the market is becoming the standard for commercial biomanufacturing. Major players are expanding capacity significantly, with CDMOs like WuXi Biologics managing substantial backlogs.

01/20/2026, 12:38 PM • GlobeNewswire

Bioconjugation Market Size to Hit USD 14.51 Billion by 2033, Driven by the Increasing Demand for Targeted Therapeutics – SNS Insider

The global bioconjugation market is projected to grow from USD 5.46 billion in 2025 to USD 14.51 billion by 2033, at a CAGR of 13.05%. Growth is driven by increasing demand for targeted therapeutics, antibody-drug conjugates, advances in conjugation chemistries, and biopharmaceutical R&D investments. North America leads with 45.50% market share, while Asia Pacific is expected to grow fastest at 14.98% CAGR. High costs and technical complexity remain challenges.

01/19/2026, 11:00 AM • GlobeNewswire

Continuous Bioprocessing Market Set to Surpass Valuation of US$ 2,331.98 Million By 2035 | Astute Analytica

The global continuous bioprocessing market is projected to grow from USD 319.77 million in 2025 to USD 2,331.98 million by 2035 at a CAGR of 21.98%. Driven by demand for biosimilars and complex biologics, manufacturers are shifting from traditional fed-batch to continuous methods, achieving 50% cost reductions and significant sustainability improvements. North America leads with 39% market share, while Asia Pacific rapidly expands capacity. Major pharmaceutical and biotech companies are deploying billions in capital investments to modernize manufacturing infrastructure.

01/16/2026, 12:38 PM • GlobeNewswire

Sterile Bioprocess Filtration Market to Hit USD 21.20 Billion by 2032, Driven by Rising Biologics Production and Adoption of Single Use Filtration Technologies - SNS Insider

The global sterile bioprocess filtration market is projected to grow from USD 5.32 billion in 2024 to USD 21.20 billion by 2032, driven by increasing biologics production, single-use technologies, and advances in membrane filtration.

12/14/2025, 8:58 AM • GlobeNewswire